In summary, the present study provides evidence that aberrant expression of SNORD12B, SNORA63, and SNORD14E in TEPs could serve as novel and non-invasive biomarkers for HBV-related HCC diagnosis. Here, SNORD12B is linked to hepatocellular carcinoma.